Press Releases

Dosed prior to surgery, Caldolor® demonstrated significant reduction in pain intensity NASHVILLE, Tenn. , Nov. 29, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company today announced the U.S. Food and Drug Administration (FDA) has approved

NASHVILLE, Tennessee — Broadwest is pleased to announce it has entered into an agreement with Cumberland Pharmaceuticals Inc. to relocate the company’s corporate offices to the Broadwest campus in the West End/Vanderbilt section of Nashville. Cumberland will establish its headquarters facility in

NASHVILLE, Tenn. , Nov. 9, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) , a specialty pharmaceutical company, today is providing a company update and third quarter 2021 financial results. Net revenues from continuing operations during the quarter were $8.1 million and

NASHVILLE, Tenn. , Nov. 2, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2021 financial results and provide a Company update after the market closes on Tuesday, November 9, 2021 .

An innovative new delivery of injectable methotrexate NASHVILLE, Tenn. , Sept. 29, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX), a specialty pharmaceutical company, announced today the national launch of its RediTrex ® (methotrexate) line of pre-filled syringes designed

Year-to-date net revenues up 9.3% NASHVILLE, Tenn. , Aug. 10, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today is providing a company update and second quarter 2021 financial results. Net revenues from continuing operations during the

NASHVILLE, Tenn. , Aug. 3, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2021 financial results and provide a Company update after the market closes on Tuesday, August 10, 2021 .

The company's 2020 sustainability report highlights its commitment to environmental, social and governance (ESG) activities NASHVILLE, Tenn. , July 26, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX) , a specialty pharmaceutical company, today released its 2020 Sustainability

NASHVILLE, Tenn. , June 21, 2021 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, today released a series of case reports describing the effectiveness of Vibativ ® ( telavancin ) in treating secondary bacterial infections in COVID-19 patients –

NASHVILLE, Tenn. , May 19, 2021 /PRNewswire/ --  Cumberland Pharmaceuticals Inc.   (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that it has promoted John Hamm to   Director Finance & Accounting and Chief Financial Officer . In this role, he will manage all of Cumberland's